198
Views
2
CrossRef citations to date
0
Altmetric
Pregnancy

First-trimester placental function in levothyroxine-using pregnant women: a case-control study

, ORCID Icon, &
Pages 233-237 | Received 19 Oct 2019, Accepted 19 Dec 2019, Published online: 30 Dec 2019

References

  • Allan WC, Haddow JE, Palomaki GE, et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen. 2000;7(3):127–130.
  • Casey BM, Dashe JS, Wells CE, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol. 2005;105(2):239–245.
  • Cleary-Goldman J, Malone FD, Lambert-Messerlian G, et al. Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol. 2008;112(1):85–92.
  • Taylor PN, Lazarus JH. Hypothyroidism in pregnancy. Endocrinol Metab Clin North Am. 2019;48(3):547–556.
  • Cignini P, Cafà EV, Giorlandino C, et al. Thyroid physiology and common diseases in pregnancy: review of literature. J Prenat Med. 2012;6(4):64–71.
  • Leung AS, Millar LK, Koonings PP, et al. Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol. 1993;81(3):349–353.
  • Su PY, Huang K, Hao JH, et al. Maternal thyroid function in the first twenty weeks of pregnancy and subsequent fetal and infant development: a prospective population-based cohort study in China. J Clin Endocrinol Metab. 2011;96(10):3234–3241.
  • Turunen S, Vääräsmäki M, Männistö T, et al. Pregnancy and perinatal outcome among hypothyroid mothers: a population-based cohort study. Thyroid. 2019;29(1):135–141.
  • Zhou M, Wang M, Li J, et al. Effects of thyroid diseases on pregnancy outcomes. Exp Ther Med. 2019;18:1807–1815.
  • Abalovich M, Gutierrez S, Alcaraz G, et al. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid. 2002;12(1):63–68.
  • Tudela CM, Casey BM, McIntire DD, et al. Relationship of subclinical thyroid disease to the incidence of gestational diabetes. Obstet Gynecol. 2012;119(5):983–988.
  • Wilson KL, Casey BM, McIntire DD, et al. Subclinical thyroid disease and the incidence of hypertension in pregnancy. Obstet Gynecol. 2012;119(2):315–320.
  • Wang S, Teng WP, Li JX, et al. Effects of maternal subclinical hypothyroidism on obstetrical outcomes during early pregnancy. J Endocrinol Invest. 2012;35(3):322–327.
  • De Groot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(8):2543–2565.
  • Verga U, Bergamaschi S, Cortelazzi D, et al. Adjustment of L-T4 substitutive therapy in pregnant women with subclinical, overt or post-ablative hypothyroidism. Clin Endocrinol (Oxf). 2009;70(5):798–802.
  • Velasco I, Taylor P. The role of levothyroxine in obstetric practice. Ann Med. 2018;50(1):57–67.
  • Barber KJ, Franklyn JA, McCabe CJ, et al. The in vitro effects of triiodothyronine on epidermal growth factor-induced trophoblast function. J Clin Endocrinol Metab. 2005;90(3):1655–1661.
  • Loubière LS, Vasilopoulou E, Bulmer JN, et al. Expression of thyroid hormone transporters in the human placenta and changes associated with intrauterine growth restriction. Placenta. 2010;31(4):295–304.
  • Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev. 2010;31(5):702–755.
  • Cartwright JE, Fraser R, Leslie K, et al. Remodelling at the maternal-fetal interface: relevance to human pregnancy disorders. Reproduction. 2010;140(6):803–813.
  • Oki N, Matsuo H, Nakago S, et al. Effects of 3,5,3’-triiodothyronine on the invasive potential and the expression of integrins and matrix metalloproteinases in cultured early placental extravillous trophoblasts. J Clin Endocrinol Metab. 2004;89(10):5213–5221.
  • Vasilopoulou E, Loubière LS, Lash GE, et al. Triiodothyronine regulates angiogenic growth factor and cytokine secretion by isolated human decidual cells in a cell-type specific and gestational age-dependent manner. Hum Reprod. 2014;29(6):1161–1172.
  • Bhide A, Acharya G, Bilardo CM, et al. ISUOG practice guidelines: use of Doppler ultrasonography in obstetrics. Ultrasound Obstet Gynecol. 2013;41(2):233–239.
  • Teng W, Shan Z, Patil-Sisodia K, et al. Hypothyroidism in pregnancy. Lancet Diabetes Endocrinol. 2013;1(3):228–237.
  • Chen LM, Du WJ, Dai J, et al. Effects of subclinical hypothyroidism on maternal and perinatal outcomes during pregnancy: a single-center cohort study of a Chinese population. PLoS One. 2014;9(10):e109364.
  • Kroopnick JM, Kim CS. Overview of hypothyroidism in pregnancy. Semin Reprod Med. 2016;34(06):323–330.
  • Wu MQ, Liu J, Wang YQ, et al. The impact of subclinical hypothyroidism on adverse perinatal outcomes and the role of thyroid screening in pregnancy. Front Endocrinol.. 2019;10:522.
  • Guttmacher AE, Maddox YT, Spong CY. The human placenta project: placental structure, development, and function in real time. Placenta. 2014;35(5):303–304.
  • Matsuo H, Maruo T, Murata K, et al. Human early placental trophoblasts produce an epidermal growth factor-like substance in synergy with thyroid hormone. Acta Endocrinol (Copenh). 1993;128(3):225–229.
  • Kwik M, Morris J. Association between first trimester maternal serum pregnancy associated plasma protein-A and adverse pregnancy outcome. Aust New Zeal J Obstet Gynaecol. 2003;43(6):438–442.
  • Spencer K, Yu CKH, Cowans NJ, et al. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free β-hCG and with second-trimester uterine artery Doppler. Prenat Diagn. 2005;25(10):949–953.
  • Barrett SL, Bower C, Hadlow NC. Use of the combined first-trimester screen result and low PAPP-A to predict risk of adverse fetal outcomes. Prenat Diagn. 2008;28(1):28–35.
  • Morris RK, Bilagi A, Devani P, et al. Association of serum PAPP-A levels in first trimester with small for gestational age and adverse pregnancy outcomes: systematic review and meta-analysis. Prenat Diagn. 2017;37(3):253–265.
  • Hershman JM. Physiological and pathological aspects of the effect of human chorionic gonadotropin on the thyroid. Best Pract Res Clin Endocrinol Metab. 2004;18(2):249–265.
  • Glinoer D. What happens to the normal thyroid during pregnancy? Thyroid. 1999;9(7):631–635.
  • Maruo T, Matsuo H, Mochizuki M. Thyroid hormone as a biological amplifier of differentiated trophoblast function in early pregnancy. Acta Endocrinol (Copenh). 1991;125(1):58–66.
  • Weinans MJ, Pratt JJ, de Wolf BT, et al. First-trimester maternal serum human thyroid-stimulating hormone in chromosomally normal and down syndrome pregnancies. Prenat Diagn. 2001;21(9):723–725.
  • Aytan H, Caliskan AC, Demirturk F, et al. Relationship between maternal thyroid hormones and the biochemical markers of the first trimester aneuploidy screening. Arch Gynecol Obstet. 2013;287(6):1125–1129.
  • Cnossen JS, Morris RK, ter Riet G, et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. Can Med Assoc J. 2008;178(6):701–711.
  • Campbell S, Griffin D, Pearce J, et al. New Doppler technique for assessing uteroplacental blood flow. Lancet. 1983;321(8326):675–677.
  • Verburg BO, Jaddoe VV, Wladimiroff JW, et al. Fetal hemodynamic adaptive changes related to intrauterine growth: the Generation R Study. Circulation. 2008;117(5):649–659.
  • Gagnon R. Placental insufficiency and its consequences. Eur J Obstet Gynecol Reprod Biol. 2003;110(1):S99–S107.
  • Baschat AA, Hecher K. Fetal growth restriction due to placental disease. Semin Perinatol. 2004;28(1):67–80.
  • Barjaktarovic M, Korevaar TIM, Chaker L, et al. The association of maternal thyroid function with placental hemodynamics. Hum Reprod. 2017;32(3):653–661.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.